Creegan & Nassoura Financial Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.89M |
| 2 |
Intel
INTC
|
+$2.31M |
| 3 |
Lockheed Martin
LMT
|
+$285K |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$93K |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$61.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$618K |
| 2 |
HSBC
HSBC
|
+$377K |
| 3 |
Blackstone
BX
|
+$68K |
| 4 |
Illinois Tool Works
ITW
|
+$67.4K |
| 5 |
Abbott
ABT
|
+$54.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.63% |
| 2 | Financials | 17.41% |
| 3 | Healthcare | 16.58% |
| 4 | Consumer Staples | 12.68% |
| 5 | Technology | 9.46% |
Similar funds
Creegan & Nassoura Financial Group's Q4 2021 Portfolio in Review
As of Q4 2021, Creegan & Nassoura Financial Group held 77 positions worth $132M, up 13% from $117M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Creegan & Nassoura Financial Group deployed $4.03M of net new capital in Q4 2021, opening 2 new positions and adding to 11 existing holdings. Its largest new stake was Merck: 36,325 shares worth $2.78M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was AT&T, an estimated $618K trimmed.
- Creegan & Nassoura Financial Group's largest Q4 2021 buy was Merck: 36,325 shares worth $2.78M.
- Creegan & Nassoura Financial Group added most to Lockheed Martin in Q4 2021, an estimated $285K increase.
- Creegan & Nassoura Financial Group's biggest Q4 2021 reduction was AT&T, cutting an estimated $618K.
- Creegan & Nassoura Financial Group's ten largest holdings make up 32% of its $132M portfolio in Q4 2021.
- Creegan & Nassoura Financial Group opened 2 new positions and closed 0 in Q4 2021.
- Creegan & Nassoura Financial Group's portfolio value rose 13% quarter-over-quarter to $132M.
Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2021, filed 14 Feb 2022.